{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:44:25Z","timestamp":1791607465120,"version":"4.3.4"},"reference-count":244,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"FEDER\/COMPETE\/POCI","award":["POCI-01-0145-FEDER-006958"],"award-info":[{"award-number":["POCI-01-0145-FEDER-006958"]}]},{"name":"FEDER\/COMPETE\/POCI","award":["POCI-01-0145-FEDER-016728"],"award-info":[{"award-number":["POCI-01-0145-FEDER-016728"]}]},{"name":"PortugueseScience and Technology Foundation","award":["UID\/AGR\/04033\/2013"],"award-info":[{"award-number":["UID\/AGR\/04033\/2013"]}]},{"name":"PortugueseScience and Technology Foundation","award":["PTDC\/DES\/114122\/2009"],"award-info":[{"award-number":["PTDC\/DES\/114122\/2009"]}]},{"name":"PortugueseScience and Technology Foundation","award":["PTDC\/DTP-DES\/6077\/2014"],"award-info":[{"award-number":["PTDC\/DTP-DES\/6077\/2014"]}]},{"name":"PortugueseScience and Technology Foundation","award":["SFRH\/BD\/102099\/2014"],"award-info":[{"award-number":["SFRH\/BD\/102099\/2014"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.lfs.2016.12.008","type":"journal-article","created":{"date-parts":[[2016,12,14]],"date-time":"2016-12-14T05:46:02Z","timestamp":1481694362000},"page":"27-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"special_numbering":"C","title":["Antihistamines as promising drugs in cancer therapy"],"prefix":"10.1016","volume":"172","author":[{"given":"Ana I.","family":"Faustino-Rocha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adelina","family":"Gama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula A.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rio","family":"Ginja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2016.12.008_bb0005","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1200\/JCO.2005.04.8678","article-title":"Clinical cancer advances 2005: major research advances in cancer treatment, prevention, and screening - a report from the American Society of Clinical Oncology","volume":"24","author":"Herbst","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0010","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3892\/or_00000867","article-title":"Dehydroepiandrosterone intake protects against 7,12-dimethylbenz(a)anthracene-induced mammary tumor development in the obese Zucker rat model","volume":"24","author":"Hakkak","year":"2010","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.lfs.2016.12.008_bb0015","series-title":"World Cancer Report 2014","author":"Stewart","year":"2014"},{"key":"10.1016\/j.lfs.2016.12.008_bb0020","series-title":"Radiobiol. Radiol","first-page":"274","article-title":"Cancer biology","author":"Hall","year":"2006"},{"key":"10.1016\/j.lfs.2016.12.008_bb0025","series-title":"Introd. to Cell. Mol. Biol. Cancer","first-page":"1","article-title":"What is cancer?","author":"Frank","year":"2005"},{"key":"10.1016\/j.lfs.2016.12.008_bb0030","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2016.12.008_bb0035","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1242\/jcs.116392","article-title":"The tumor microenvironment at a glance","volume":"125","author":"Balkwill","year":"2012","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.lfs.2016.12.008_bb0040","doi-asserted-by":"crossref","first-page":"F23","DOI":"10.1084\/jem.193.6.F23","article-title":"Inflammatory cells and cancer: think different!","volume":"193","author":"Coussens","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.lfs.2016.12.008_bb0045","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","article-title":"Accessories to the crime: functions of cells recruited to the tumor microenvironment","volume":"21","author":"Hanahan","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.lfs.2016.12.008_bb0050","doi-asserted-by":"crossref","DOI":"10.1186\/1478-811X-9-18","article-title":"Interaction of tumor cells with the microenvironment","volume":"9","author":"Ungefroren","year":"2011","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.lfs.2016.12.008_bb0055","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nature09707","article-title":"Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling","volume":"470","author":"Tan","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2016.12.008_bb0060","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1158\/0008-5472.CAN-04-3444","article-title":"CD4(+) T cell-mediated antigen-specific immunotherapy in a mouse model of cervical cancer","volume":"65","author":"Daniel","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2016.12.008_bb0065","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1038\/sj.onc.1205291","article-title":"Complex roles of tissue inhibitors of metalloproteinases in cancer","volume":"21","author":"Jiang","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.lfs.2016.12.008_bb0070","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2016.12.008_bb0075","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2016.12.008_bb0080","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2016.12.008_bb0085","series-title":"Beitr\u00e4ge zur Theorie und Praxis der Histologischen F\u00e4rbung","author":"Ehrlich","year":"1878"},{"key":"10.1016\/j.lfs.2016.12.008_bb0090","series-title":"Mast Cells Tumors From Biol. to Clin","first-page":"3","article-title":"The mast cell","author":"Ribatti","year":"2011"},{"key":"10.1016\/j.lfs.2016.12.008_bb0095","series-title":"Mast Cells Tumors from Biol. to Clin","first-page":"83","article-title":"Mast cells and tumors","author":"Ribatti","year":"2011"},{"key":"10.1016\/j.lfs.2016.12.008_bb0100","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/ni1503","article-title":"Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B","volume":"8","author":"Grimbaldeston","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0105","doi-asserted-by":"crossref","DOI":"10.1096\/fj.06-5837fje","article-title":"Mast cells are required for normal healing of skin wounds in mice","volume":"20","author":"Weller","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.lfs.2016.12.008_bb0110","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0166-2236(96)81863-7","article-title":"Mast cells in the brain: evidence and functional significance","volume":"19","author":"Silver","year":"1996","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.lfs.2016.12.008_bb0115","series-title":"Mast Cell Biol. Contemp. Emerg. Top","first-page":"107","article-title":"The mechanism of exocytosis in mast cells","author":"Blank","year":"2011"},{"key":"10.1016\/j.lfs.2016.12.008_bb0120","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1469-185X.2009.00105.x","article-title":"The mast cell: an evolutionary perspective","volume":"85","author":"Crivellato","year":"2010","journal-title":"Biol. Rev."},{"key":"10.1016\/j.lfs.2016.12.008_bb0125","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1369\/jhc.5R6647.2005","article-title":"Ultrastructural studies of human basophils and mast cells","volume":"53","author":"Dvorak","year":"2005","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.lfs.2016.12.008_bb0130","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF00232005","article-title":"Long-term increase of mucosal mast-cells in the rat induced by administration of compound 48\u201380","volume":"198","author":"Enerback","year":"1979","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.lfs.2016.12.008_bb0135","series-title":"Mast Cell Biol. Contemp. Emerg. Top","first-page":"47","article-title":"Mast cell apoptosis and survival","author":"Ekoff","year":"2011"},{"key":"10.1016\/j.lfs.2016.12.008_bb0140","first-page":"105","article-title":"Growth of human mast cells from bone marrow and peripheral blood-derived CD34_+_pluripotent progenitor cells","volume":"315","author":"Kirshenbaum","year":"2006","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.194.1.F1","article-title":"The diverse role of mast cells","volume":"194","author":"Gurish","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.lfs.2016.12.008_bb0150","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1385\/IR:34:2:97","article-title":"Development migration, and survival of mast cells","volume":"34","author":"Okayama","year":"2006","journal-title":"Immunol. Res."},{"key":"10.1016\/j.lfs.2016.12.008_bb0155","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1182\/blood.V52.2.447.447","article-title":"Decrease of mast-cells in W-W Nu mice and their increase by bone-marrow transplantation","volume":"52","author":"Kitamura","year":"1978","journal-title":"Blood"},{"key":"10.1016\/j.lfs.2016.12.008_bb0160","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1007\/s00018-004-4273-y","article-title":"Kit as a human oncogenic tyrosine kinase","volume":"61","author":"Kitamura","year":"2004","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.lfs.2016.12.008_bb0165","series-title":"Mast Cell Biol. Contemp. Emerg. Top","first-page":"2","article-title":"Mast cell biology: introduction and overview","author":"Gilfillan","year":"2011"},{"key":"10.1016\/j.lfs.2016.12.008_bb0170","series-title":"Mast Cell Biol. Contemp. Emerg. Top","first-page":"29","article-title":"Monomeric IgE and mast cell development, survival and function","author":"Kashiwakura","year":"2011"},{"key":"10.1016\/j.lfs.2016.12.008_bb0175","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.it.2007.06.007","article-title":"Mast cells as effector cells: a co-stimulating question","volume":"28","author":"Bachelet","year":"2007","journal-title":"Trends Immunol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0180","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri1460","article-title":"Mast-cell responses to pathogens","volume":"4","author":"Marshall","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0185","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature07204","article-title":"The development of allergic inflammation","volume":"454","author":"Galli","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2016.12.008_bb0190","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.it.2004.03.005","article-title":"The ins and outs of IgE-dependent mast-cell exocytosis","volume":"25","author":"Blank","year":"2004","journal-title":"Trends Immunol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0195","doi-asserted-by":"crossref","first-page":"6915","DOI":"10.4049\/jimmunol.165.12.6915","article-title":"A role for CD21\/CD35 and CD19 in responses to acute septic peritonitis: a potential mechanism for mast cell activation","volume":"165","author":"Gommerman","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0200","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1128\/IAI.69.1.413-419.2001","article-title":"Role of Fc gamma receptors in triggering host cell activation and cytokine release by Borrelia burgdorferi","volume":"69","author":"Talkington","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.lfs.2016.12.008_bb0205","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1365-2141.2009.07938.x","article-title":"The fundamental contribution of William Bate Hardy to shape the concept of mast cell heterogeneity","volume":"150","author":"Crivellato","year":"2010","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0210","first-page":"5","article-title":"New insight into \u201cthe riddle of mast cells\u201d: microenvironmental regulation of mast cell development and phenotypic heterogeneity","volume":"62","author":"Galli","year":"1990","journal-title":"Lab. Investig."},{"key":"10.1016\/j.lfs.2016.12.008_bb0215","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1471-4906(01)02156-1","article-title":"The role of mast cells in host defense and their subversion by bacterial pathogens","volume":"23","author":"Feger","year":"2002","journal-title":"Trends Immunol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0220","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.jaci.2006.04.017","article-title":"Mast cells: ontogeny, homing, and recruitment of a unique innate effector cell","volume":"117","author":"Gurish","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0225","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1182\/blood-2007-07-104018","article-title":"Phagocytosis-independent antimicrobial activity of mast cells by means of extracellular trap formation","volume":"111","author":"Kockritz-Blickwede","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.lfs.2016.12.008_bb0230","series-title":"Mast Cell Biol. Contemp. Emerg. Top","first-page":"162","article-title":"The mast cell in innate and adaptative immunity","author":"Shelburne","year":"2011"},{"key":"10.1016\/j.lfs.2016.12.008_bb0235","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/eji.200838899","article-title":"Our perception of the mast cell from Paul Ehrlich to now","volume":"39","author":"Beaven","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0240","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1146\/annurev.immunol.21.120601.141025","article-title":"Mast cells as \u201ctunable\u201d effector and immunoregulatory cells: recent advances","volume":"23","author":"Galli","year":"2005","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0245","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1084\/jem.170.1.245","article-title":"Interleukin-3-dependent and interleukin-3-independent mast-cells stimulated with Ige and antigen express multiple cytokines","volume":"170","author":"Burd","year":"1989","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.lfs.2016.12.008_bb0250","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/339064a0","article-title":"Mast-cell lines produce lymphokines in response to cross-linkage of Fc-epsilon-Ri or to calcium ionophores","volume":"339","author":"Plaut","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2016.12.008_bb0255","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1365-2796.2000.00742.x","article-title":"Infections as a major preventable cause of human cancer","volume":"248","author":"Kuper","year":"2000","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.lfs.2016.12.008_bb0260","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1016\/S0002-9440(10)65517-4","article-title":"Proliferative inflammatory atrophy of the prostate - implications for prostatic carcinogenesis","volume":"155","author":"De Marzo","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0265","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2012.00119","article-title":"Mast cell chemotaxis - chemoattractants and signaling pathways","volume":"3","author":"Halova","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0270","series-title":"Mast Cells and Tumors: From Biology to Clinic","author":"Ribatti","year":"2011"},{"key":"10.1016\/j.lfs.2016.12.008_bb0275","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/ijc.2910180520","article-title":"Mast-cells and tumor angiogenesis","volume":"18","author":"Kessler","year":"1976","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.lfs.2016.12.008_bb0280","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.molimm.2014.02.020","article-title":"Mast cells as targets for immunotherapy of solid tumors","volume":"63","author":"Oldford","year":"2014","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0285","first-page":"5860","article-title":"Mast cells as target in cancer therapy","volume":"15","author":"Groot","year":"2009","journal-title":"Curr. Pramaceutical Des."},{"key":"10.1016\/j.lfs.2016.12.008_bb0290","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Inflammation and cancer: back to Virchow?","volume":"357","author":"Balkwill","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2016.12.008_bb0295","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0046-8177(99)90215-0","article-title":"At the crossroad of tumorigenesis: drivers and hitchhikers","volume":"30","author":"Cordon-Cardo","year":"1999","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0300","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4255\/mcpharmacol.09.05","article-title":"Anti-inflammatory agents for cancer therapy","volume":"1","author":"Rayburn","year":"2009","journal-title":"Mol. Cell. Pharmacol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0305","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2016.12.008_bb0310","first-page":"G515","article-title":"Inflammation and cancer - II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy","volume":"286","author":"Macarthur","year":"2004","journal-title":"Am. J. Physiol. Liver Physiol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0315","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.4049\/jimmunol.174.3.1647","article-title":"Decoy receptor 3 increases monocyte adhesion to endothelial cells via NF-kappa B-dependent up-regulation of intercellular adhesion molecule-1, VCAM-1, and IL-8 expression","volume":"174","author":"Yang","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0320","series-title":"Mast Cell Biol. Contemp. Emerg. Top","first-page":"270","article-title":"Mast cells, angiogenesis and cancer","author":"Ribatti","year":"2011"},{"key":"10.1016\/j.lfs.2016.12.008_bb0325","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/ijc.2910410415","article-title":"Inflammatory cell infiltrates in human-melanoma at different stages of tumor progression","volume":"41","author":"Brocker","year":"1988","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.lfs.2016.12.008_bb0330","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1093\/jnci\/91.17.1459","article-title":"Possible role of ovarian epithelial inflammation in ovarian cancer","volume":"91","author":"Ness","year":"1999","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.lfs.2016.12.008_bb0335","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1146\/annurev.micro.54.1.615","article-title":"The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer","volume":"54","author":"Ernst","year":"2000","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0340","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/jnci\/86.2.120","article-title":"Anti-colony-stimulating factor-I antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosis","volume":"86","author":"Scholl","year":"1994","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.lfs.2016.12.008_bb0345","doi-asserted-by":"crossref","DOI":"10.1186\/bcr1648","article-title":"Oestrogen receptor negative breast cancers exhibit high cytokine content","volume":"9","author":"Chavey","year":"2007","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.lfs.2016.12.008_bb0350","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1002\/pros.20464","article-title":"Monocyte chemotactic protein-1 (MCP-1) acts as a paracrine and autocrine factor for prostate cancer growth and invasion","volume":"66","author":"Lu","year":"2006","journal-title":"Prostate"},{"key":"10.1016\/j.lfs.2016.12.008_bb0355","doi-asserted-by":"crossref","first-page":"5093","DOI":"10.1038\/sj.onc.1206557","article-title":"Molecular viral oncology of hepatocellular carcinoma","volume":"22","author":"Block","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.lfs.2016.12.008_bb0360","first-page":"S1929","article-title":"Inflammation, chromosomal instability, and cancer - the schistosomiasis model","volume":"54","author":"Rosin","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2016.12.008_bb0365","first-page":"96","article-title":"Urinary schistosomiasis with simultaneous bladder squamous cell carcinoma and transitional cell carcinoma","volume":"7","author":"Ketabchi","year":"2012","journal-title":"Iran. J. Parasitol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0370","doi-asserted-by":"crossref","DOI":"10.1186\/1750-9378-8-19","article-title":"Schistosomiasis and urinary bladder cancer in North Western Tanzania: a retrospective review of 185 patients","volume":"8","author":"Rambau","year":"2013","journal-title":"Infect. Agent. Cancer"},{"key":"10.1016\/j.lfs.2016.12.008_bb0375","first-page":"G7","article-title":"Inflammation and cancer - IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation","volume":"287","author":"Itzkowitz","year":"2004","journal-title":"Am. J. Physiol. Liver Physiol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0380","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/carcin\/24.3.353","article-title":"Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models","volume":"24","author":"Seril","year":"2003","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.lfs.2016.12.008_bb0385","first-page":"G315","article-title":"Inflammation and cancer - V. Chronic pancreatitis and pancreatic cancer","volume":"287","author":"Whitcomb","year":"2004","journal-title":"Am. J. Physiol. Liver Physiol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0390","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1093\/ije\/22.6.976","article-title":"Cancer incidence among 78,000 asthmatic-patients","volume":"22","author":"Vesterinen","year":"1993","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0395","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1093\/oxfordjournals.aje.a117366","article-title":"Previous lung-disease and risk of lung-cancer among lifetime nonsmoking women in the United-States","volume":"141","author":"Wu","year":"1995","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0400","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1164\/ajrccm.160.5.9904045","article-title":"Increased risk for cancer following sarcoidosis","volume":"160","author":"Askling","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.lfs.2016.12.008_bb0405","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0046-8177(98)90198-8","article-title":"Vulvar lichen sclerosus and squamous cell carcinoma: a cohort, case control, and investigational study with historical perspective; implications for chronic inflammation and sclerosis in the development of neoplasia","volume":"29","author":"Carlson","year":"1998","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0410","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1524-4725.1988.tb01150.x","article-title":"Verrucous carcinoma arising in ulcerative lichen planus of the soles","volume":"14","author":"Mayron","year":"1988","journal-title":"J. Dermatol. Surg. Oncol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0415","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-3-642-81095-4_11","article-title":"Epidemiology of cancer of the penis","volume":"60","author":"Perky","year":"1977","journal-title":"Recent Results Cancer Res."},{"key":"10.1016\/j.lfs.2016.12.008_bb0420","first-page":"447","article-title":"Pelvic inflammatory disease and the risk of epithelial ovarian-cancer","volume":"4","author":"Risch","year":"1995","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.lfs.2016.12.008_bb0425","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1093\/carcin\/bgh317","article-title":"Prostate carcinogenesis and inflammation: emerging insights","volume":"26","author":"Palapattu","year":"2005","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.lfs.2016.12.008_bb0430","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1398-9995.2005.00808.x","article-title":"Allergy and cancer","volume":"60","author":"Lindelof","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.lfs.2016.12.008_bb0435","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1002\/ijc.21752","article-title":"An overview of the association between allergy and cancer","volume":"118","author":"Turner","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.lfs.2016.12.008_bb0440","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042896","article-title":"Association between common allergic symptoms and cancer in the NHANES III female cohort","volume":"7","author":"Chae","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2016.12.008_bb0445","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/bjc.1983.277","article-title":"Allergies and agricultural exposure as risk-factors for multiple-myeloma","volume":"48","author":"Gallagher","year":"1983","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.lfs.2016.12.008_bb0450","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1023\/A:1023982402137","article-title":"A meta-analysis of asthma and risk of lung cancer (United States)","volume":"14","author":"Santillan","year":"2003","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.lfs.2016.12.008_bb0455","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jaad.2003.09.024","article-title":"The lack of a relationship between atopic dermatitis and nonmelanoma skin cancers","volume":"50","author":"Ming","year":"2004","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0460","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/ijc.11230","article-title":"Cohort studies of association between self-reported allergic conditions, immune-related diagnoses and glioma and meningioma risk","volume":"106","author":"Schwartzbaum","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.lfs.2016.12.008_bb0465","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/aje\/kwi241","article-title":"Is the risk of lung cancer reduced among eczema patients?","volume":"162","author":"Castaing","year":"2005","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0470","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/ijc.11054","article-title":"Atopic disease and childhood acute lymphoblastic leukemia","volume":"105","author":"Schuz","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.lfs.2016.12.008_bb0475","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/sj.bjc.6690395","article-title":"Association of childhood leukaemia with factors related to the immune system","volume":"80","author":"Schuz","year":"1999","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.lfs.2016.12.008_bb0480","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/ijc.10320","article-title":"History of allergies and autoimmune diseases and risk of brain tumors in adults","volume":"99","author":"Brenner","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.lfs.2016.12.008_bb0485","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1093\/aje\/kwm203","article-title":"Allergic conditions and brain tumor risk","volume":"166","author":"Wigertz","year":"2007","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0490","series-title":"Drug Dev. - a Case Study Based Insight into Mod. Strateg","first-page":"75","article-title":"Histamine receptors as potential therapeutic targets for cancer drug development","author":"Medina","year":"2011"},{"key":"10.1016\/j.lfs.2016.12.008_bb0495","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3322\/caac.20132","article-title":"Immunotherapy of cancer in 2012, Ca-A","volume":"62","author":"Kirkwood","year":"2012","journal-title":"Cancer J. Clin."},{"key":"10.1016\/j.lfs.2016.12.008_bb0500","doi-asserted-by":"crossref","first-page":"495","DOI":"10.5306\/wjco.v5.i3.495","article-title":"Pattern response of dendritic cells in the tumor microenvironment and breast cancer","volume":"5","author":"Cunha","year":"2014","journal-title":"World J. Clin. Oncol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0505","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.jaci.2004.03.024","article-title":"Mechanisms of immunotherapy","volume":"111","author":"Till","year":"2004","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0510","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1067\/mai.2003.84","article-title":"Immunotherapy of allergic disease","volume":"111","author":"Frew","year":"2003","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0515","doi-asserted-by":"crossref","first-page":"S763","DOI":"10.1016\/S0091-6749(97)70125-8","article-title":"Pathogenesis of allergic rhinitis","volume":"99","author":"Baraniuk","year":"1997","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0520","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1113\/jphysiol.1910.sp001406","article-title":"The physiological action of beta-iminazolylethylamine","volume":"41","author":"Dale","year":"1910","journal-title":"J. Physiol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0525","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.cytogfr.2004.06.003","article-title":"Histamine-cytokine connection in immunity and hematopoiesis","volume":"15","author":"Dy","year":"2004","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.lfs.2016.12.008_bb0530","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1164\/ajrccm\/139.3.791","article-title":"The patho-physiology of rhinitis. 2. Assessment of the sources of protein in histamine-induced nasal secretions","volume":"139","author":"Raphael","year":"1989","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.lfs.2016.12.008_bb0535","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1113\/jphysiol.1919.sp001837","article-title":"Histamine shock","volume":"52","author":"Dale","year":"1919","journal-title":"J. Physiol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0540","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0091-6749(05)80223-4","article-title":"The role of histamine in allergic diseases","volume":"28","author":"White","year":"1990","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0545","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/ajcn\/85.5.1185","article-title":"Histamine and histamine intolerance","volume":"85","author":"Maintz","year":"2007","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.lfs.2016.12.008_bb0550","first-page":"214","article-title":"Beta-imidazol aethyl amines and the organ extracts. First part: beta-imidazol aethyl amine as a powerful stimulant of the stomach glands","volume":"177","author":"Popielski","year":"1919","journal-title":"Pflugers Arch. Gesamte Physiol. Menschen Tiere"},{"key":"10.1016\/j.lfs.2016.12.008_bb0555","series-title":"Drug Class Review: Newer Antihistamines","author":"Carson","year":"2010"},{"key":"10.1016\/j.lfs.2016.12.008_bb0560","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1038\/sj.bjp.0706440","article-title":"Histamine and its receptors","volume":"147","author":"Parsons","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0565","first-page":"16","article-title":"Antihistamines: a brief review","volume":"16","author":"Van Schoor","year":"2012","journal-title":"Prof. Nurs. Today"},{"key":"10.1016\/j.lfs.2016.12.008_bb0570","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1056\/NEJM197601012940108","article-title":"Histamine. 1","volume":"294","author":"Beaven","year":"1976","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2016.12.008_bb0575","first-page":"1311","article-title":"Histamine and gastric secretion - a later look 1955\u20131965","volume":"24","author":"Code","year":"1965","journal-title":"Fed. Proc."},{"key":"10.1016\/j.lfs.2016.12.008_bb0580","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1471-4159.1980.tb12485.x","article-title":"Neurotransmitter in mammalian brain - neurochemical evidence","volume":"35","author":"Schwartz","year":"1980","journal-title":"J. Neurochem."},{"key":"10.1016\/j.lfs.2016.12.008_bb0585","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2165\/00003495-200565030-00004","article-title":"Second-generation antihistamines: actions and efficacy in the managment of allergic disorders","volume":"65","author":"Golightly","year":"2005","journal-title":"Drugs"},{"key":"10.1016\/j.lfs.2016.12.008_bb0590","first-page":"1","article-title":"Histamine in chronic allergic responses","volume":"15","author":"Jutel","year":"2005","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0595","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1046\/j.0954-7894.2002.01314.x","article-title":"H-1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects","volume":"32","author":"Leurs","year":"2002","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.lfs.2016.12.008_bb0600","first-page":"143","article-title":"Proyecci\u00f3n de los nuevos antihistam\u00ednicos","volume":"28","author":"Eseverri","year":"2000","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.lfs.2016.12.008_bb0605","doi-asserted-by":"crossref","DOI":"10.1038\/nrd1631","article-title":"The histamine H-3 receptor: from gene cloning to H-3 receptor drugs","volume":"4","author":"Leurs","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.lfs.2016.12.008_bb0610","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1124\/mol.55.6.1101","article-title":"Cloning and functional expression of the human histamine H-3 receptor","volume":"55","author":"Lovenberg","year":"1999","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0615","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/302832a0","article-title":"Auto-inhibition of brain histamine-release mediated by a novel class (H-3) of histamine-receptor","volume":"302","author":"Arrang","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2016.12.008_bb0620","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.bcp.2007.01.008","article-title":"Molecular aspects of the histamine H-3 receptor","volume":"73","author":"Bongers","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0625","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1476-5381.2009.00151.x","article-title":"The role of histamine H-4 receptor in immune and inflammatory disorders","volume":"157","author":"Zampeli","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0630","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMra033121","article-title":"Drug therapy - advances in H-1-antihistamines","volume":"351","author":"Simons","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2016.12.008_bb0635","doi-asserted-by":"crossref","first-page":"985","DOI":"10.2741\/s203","article-title":"Pathogenetic and therapeutic implications of the histamine H4 receptor in inflammatory skin diseases and pruritus","volume":"3","author":"Gutzmer","year":"2011","journal-title":"Front. Biosci."},{"key":"10.1016\/j.lfs.2016.12.008_bb0640","series-title":"Immunobiology: The immune system in health and disease","author":"Janeway","year":"2001"},{"key":"10.1016\/j.lfs.2016.12.008_bb0645","series-title":"Mast Cells Tumors From Biol. to Clin","first-page":"89","article-title":"Mast cells and tumor angiogenesis","author":"Ribatti","year":"2011"},{"key":"10.1016\/j.lfs.2016.12.008_bb0650","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1152\/physrev.1968.48.1.155","article-title":"New approaches to the physiology of histamine","volume":"48","author":"Kahlson","year":"1965","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0655","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1136\/gut.35.11.1632","article-title":"Cimetidine inhibits in-vivo growth of human colon-cancer and reverses histamine-stimulated in-vitro and in-vivo growth","volume":"35","author":"Adams","year":"1994","journal-title":"Gut"},{"key":"10.1016\/j.lfs.2016.12.008_bb0660","first-page":"639","article-title":"Involvement of histamine in growth of mouse and rat-tumors - antitumoral properties of monofluoromethylhistidine, an enzyme-activated irreversible inhibitor of histidine-decarboxylase","volume":"44","author":"Bartholeyns","year":"1984","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2016.12.008_bb0665","doi-asserted-by":"crossref","DOI":"10.1007\/BF01895530","article-title":"Retardation of protein synthesis in rat tumours on inhibiting histamine formation","volume":"26","author":"Grahn","year":"1970","journal-title":"Experientia"},{"key":"10.1016\/j.lfs.2016.12.008_bb0670","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0304-3835(95)90153-1","article-title":"Diamine-oxidase activity and tissue di- and poly-amine contents of human ovarian, cervical and endometrial carcinoma","volume":"89","author":"Chanda","year":"2001","journal-title":"Cancer Lett."},{"key":"10.1016\/j.lfs.2016.12.008_bb0675","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/BF02142587","article-title":"Increased histidine-decarboxylase (Hdc) activity in human colorectal-cancer - results of a study on 10 patients","volume":"23","author":"Garciacaballero","year":"1988","journal-title":"Agents Actions"},{"key":"10.1016\/j.lfs.2016.12.008_bb0680","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0960-7404(94)90046-9","article-title":"Histamine synthesis and content in benign and malignant breast-tumors - its effects on other host tissues","volume":"3","author":"Garciacaballero","year":"1994","journal-title":"Surg. Oncol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0685","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0002-9440(10)61102-9","article-title":"Expression of histidine decarboxylase and synthesis of histamine by human small cell lung carcinoma","volume":"160","author":"Graff","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0690","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.0022-202x.2001.01406.x","article-title":"Suppression of melanoma cell proliferation by histidine decarboxylase specific antisense oligonucleotides","volume":"117","author":"Hegyesi","year":"2001","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0695","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/BF00398182","article-title":"Blood histamine and solid malignant-tumors","volume":"114","author":"Moriarty","year":"1988","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0700","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4161\/cbt.7.1.5706","article-title":"Histamine in cancer - the dual faces of the coin","volume":"7","author":"Cianchi","year":"2008","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.lfs.2016.12.008_bb0705","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/emm.2007.32","article-title":"Histamine and spontaneously released mast cell granules affect the cell growth of human hepatocellular carcinoma cells","volume":"39","author":"Lamplasi","year":"2007","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.lfs.2016.12.008_bb0710","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1006\/scbi.2000.0303","article-title":"Histamine as an autocrine growth factor: an unusual role for a widespread mediator","volume":"10","author":"Rivera","year":"2000","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0715","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1007\/s00011-003-0331-4","article-title":"Histamine regulates the MAPK pathway via the H-2 receptor in PANC-1 human cells","volume":"53","author":"Cricco","year":"2004","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.lfs.2016.12.008_bb0720","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/1523-1747.ep12538356","article-title":"The effect of histamine, antihistamines, and a mast-cell stabilizer on the growth of Cloudman melanoma-cells in dba\/2 mice","volume":"81","author":"Nordlund","year":"1983","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0725","doi-asserted-by":"crossref","first-page":"5052","DOI":"10.1073\/pnas.79.16.5052","article-title":"T-cell suppression and Contrasuppression induced by histamine H-2 and H-1 receptor agonists, respectively","volume":"79","author":"Siegel","year":"1982","journal-title":"Proc. Natl. Acad. Sci. United States Am. Sci."},{"key":"10.1016\/j.lfs.2016.12.008_bb0730","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/bjc.1996.155","article-title":"Ranitidine and cimetidine differ in their in vitro and in vivo effects on human colonic cancer growth","volume":"73","author":"Lawson","year":"1996","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.lfs.2016.12.008_bb0735","first-page":"2995","article-title":"Expression of Ki-67 and p53 in rat urothelial lesions induced by N-butyl-N-(4-hydroxybutyl) nitrosamine and treated with mitomycin C and bacillus Calmette-Gu\u00e9rin","volume":"26","author":"Oliveira","year":"2006","journal-title":"Anticancer Res."},{"key":"10.1016\/j.lfs.2016.12.008_bb0740","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1615\/JEnvironPatholToxicolOncol.2013007541","article-title":"MNU-induced rat mammary carcinomas: immunohistology and estrogen receptor expression","volume":"32","author":"Soares-Maia","year":"2013","journal-title":"J. Environ. Pathol. Toxicol. Oncol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0745","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3109\/09553002.2010.533247","article-title":"Histamine prevents functional and morphological alterations of submandibular glands induced by ionising radiation","volume":"87","author":"Medina","year":"2011","journal-title":"Int. J. Radiat. Biol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0750","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1080\/09553000701570238","article-title":"Mechanisms underlying the radioprotective effect of histamine on small intestine","volume":"83","author":"Medina","year":"2007","journal-title":"Int. J. Radiat. Biol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0755","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4081\/ejh.2012.e48","article-title":"Radioprotective potential of histamine on rat small intestine and uterus","volume":"56","author":"Carabajal","year":"2012","journal-title":"Eur. J. Histochem."},{"key":"10.1016\/j.lfs.2016.12.008_bb0760","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4161\/15384047.2014.987091","article-title":"Enhancement of ionizing radiation response by histamine in vitro and in vivo in human breast cancer","volume":"16","author":"Martinel Lamas","year":"2015","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.lfs.2016.12.008_bb0765","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4103\/2141-9248.126619","article-title":"An evaluation of hepatotoxicity in breast cancer patients receiving injection doxorubicin","volume":"4","author":"Damodar","year":"2014","journal-title":"Ann. Med. Health Sci. Res."},{"key":"10.1016\/j.lfs.2016.12.008_bb0770","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.378","article-title":"Histamine: a potential cytoprotective agent to improve cancer therapy?","volume":"6","author":"Martinel Lamas","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2016.12.008_bb0775","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ejps.2011.02.004","article-title":"Cimetidine: an anticancer drug?","volume":"42","author":"Kubecova","year":"2011","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.lfs.2016.12.008_bb0780","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF02005757","article-title":"An autocrine growth-factor in experimental mammary carcinomas","volume":"43","author":"Cricco","year":"1994","journal-title":"Agents Actions"},{"key":"10.1016\/j.lfs.2016.12.008_bb0785","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0006-2952(95)00108-C","article-title":"H-1 and H-2 histamine-receptors in N-nitroso-N-methylurea (Nmu)-induced carcinomas with atypical coupling to signal transducers","volume":"50","author":"Davio","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0790","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0014-5793(00)01560-X","article-title":"Switch of histamine receptor expression from H2 to H1 during differentiation of monocytes into macrophages","volume":"473","author":"Wang","year":"2000","journal-title":"FEBS Lett."},{"key":"10.1016\/j.lfs.2016.12.008_bb0795","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1046\/j.1365-2362.2002.01020.x","article-title":"Inhibition of human primary melanoma cell proliferation by histamine is enhanced by interleukin-6","volume":"32","author":"Lazar-Molnar","year":"2002","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.lfs.2016.12.008_bb0800","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1007\/s00011-006-0516-8","article-title":"Locally secreted histamine may regulate the development of ovarian follicles by apoptosis","volume":"56","author":"Szukiewicz","year":"2007","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.lfs.2016.12.008_bb0805","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1136\/gut.2004.061762","article-title":"Selective expression of histamine receptors H1R, H2R, and H4R, but not H3R, in the human intestinal tract","volume":"55","author":"Sander","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.lfs.2016.12.008_bb0810","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4161\/cbt.7.1.5123","article-title":"The role of histamine in human mammary carcinogenesis - H3 and H4 receptors as potential therapeutic targets for breast cancer treatment","volume":"7","author":"Medina","year":"2008","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.lfs.2016.12.008_bb0815","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1476-5381.2010.00961.x","article-title":"Histamine receptors and cancer pharmacology","volume":"161","author":"Medina","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0820","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2222.1990.tb02456.x","article-title":"The pharmacology and mechanisms of action of histamine-H1-antagonists","volume":"20","author":"Rimmer","year":"1990","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.lfs.2016.12.008_bb0825","first-page":"606","article-title":"Inhibition of amine oxidase by antihistamine compunds and related drugs","volume":"6","author":"Tickner","year":"1951","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0830","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1210\/endo-112-2-425","article-title":"Antiestrogen-binding sites distinct from the estrogen-receptor - subcellular-localization, ligand specificity, and distribution in tissues of the rat","volume":"112","author":"Sudo","year":"1983","journal-title":"Endocrinology"},{"key":"10.1016\/j.lfs.2016.12.008_bb0835","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/ijc.11240","article-title":"Antihistamine use and breast cancer risk","volume":"106","author":"Nadalin","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.lfs.2016.12.008_bb0840","series-title":"Antihistamine Drugs","author":"A.S. of H.-S. Pharmacists","year":"2014"},{"key":"10.1016\/j.lfs.2016.12.008_bb0845","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1517\/13543784.7.7.1045","article-title":"Therapeutic advantages of third generation antihistamines","volume":"7","author":"Handley","year":"1998","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.lfs.2016.12.008_bb0850","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1185\/030079904X13266","article-title":"Allergic rhinitis and impairment issues in school children: a consensus report","volume":"20","author":"Blaiss","year":"2004","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.lfs.2016.12.008_bb0855","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1111\/j.1398-9995.2008.01771.x","article-title":"New oral H1 antihistamines in children: facts and unmeet needs","volume":"63","author":"De Benedictis","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.lfs.2016.12.008_bb0860","first-page":"3","article-title":"Comparative pharmacology of the H1 antihistamines","volume":"16","author":"Del Cuvillo","year":"2006","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0865","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1590\/S0365-05962010000200010","article-title":"Histamine, histamine receptors and antihistamines: new concepts","volume":"85","author":"Criado","year":"2010","journal-title":"An. Bras. Dermatol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0870","first-page":"29","article-title":"Interactions of the H1 antihistamines","volume":"16","author":"Bartra","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0875","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2165\/00002018-199920050-00001","article-title":"Comparative tolerability of second generation antihistamines","volume":"20","author":"Horak","year":"1999","journal-title":"Drug Saf."},{"key":"10.1016\/j.lfs.2016.12.008_bb0880","series-title":"Understanding and Managing Your Child's Food Allergies","author":"Sicherer","year":"2006"},{"key":"10.1016\/j.lfs.2016.12.008_bb0885","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.bjp.0701576","article-title":"Role of mast cells, neutrophils and nitric oxide in endotoxin-induced damage to the neonatal rat colon","volume":"123","author":"Brown","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0890","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2165\/00003495-199040030-00006","article-title":"Ketotifen - a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma and allergic disorders","volume":"40","author":"Grant","year":"1990","journal-title":"Drugs"},{"key":"10.1016\/j.lfs.2016.12.008_bb0895","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/BF00505315","article-title":"Dissociation between the anti-anaphylactic and the anti-histaminic actions of ketotifen","volume":"316","author":"Martin","year":"1981","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0900","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1038\/jid.2009.134","article-title":"Deslorataine inhibits human skin mast cell activation and histamine release","volume":"129","author":"Weller","year":"2009","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0905","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1124\/mol.60.5.1133","article-title":"Histamine H-1-receptor activation of nuclear factor-kappa B: roles for G beta gamma- and G alpha(q\/11)-subunits in constitutive and agonist-mediated signaling","volume":"60","author":"Bakker","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0910","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1158\/1055-9965.EPI-10-0948","article-title":"Assessment of type of allergy and antihistamine use in the development of glioma","volume":"20","author":"McCarthy","year":"2011","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.lfs.2016.12.008_bb0915","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1046\/j.1365-2222.1999.0290s3197.x","article-title":"Cardiovascular profile of loratadine","volume":"29","author":"Hey","year":"1999","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.lfs.2016.12.008_bb0920","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1124\/dmd.31.3.312","article-title":"P-glycoprotein limits the brain penetration of nonsedating but not sedating H1-antagonists","volume":"31","author":"Chen","year":"2003","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.lfs.2016.12.008_bb0925","first-page":"536","article-title":"In vitro characterization of cytochrome P450 2D6 inhibition by classic histamine H-1 receptor antagonists","volume":"26","author":"Hamelin","year":"1998","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.lfs.2016.12.008_bb0930","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1067\/mai.2002.129123","article-title":"Clinical pharmacology of H-1-antihistamines in the skin","volume":"110","author":"Simons","year":"2002","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0935","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/oxfordjournals.aje.a010091","article-title":"Risk of breast cancer according to use of antidepressants, phenothiazines, and antihistamines","volume":"150","author":"Kelly","year":"1999","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0940","first-page":"5736","article-title":"Screening prescription drugs for possible carcinogenicity - 11 to 15years of follow-up","volume":"49","author":"Selby","year":"1989","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2016.12.008_bb0945","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/clpt.1998.55","article-title":"Cancer recurrences and second primary cancers after use of antihistamines or antidepressants","volume":"63","author":"Weiss","year":"1998","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.lfs.2016.12.008_bb0950","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1158\/1055-9965.EPI-07-2621","article-title":"Long-term anti-inflammatory and antihistamine medication use and adult glioma risk","volume":"17","author":"Scheurer","year":"2008","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.lfs.2016.12.008_bb0955","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1002\/1097-0142(19920515)69:10<2541::AID-CNCR2820691025>3.0.CO;2-H","article-title":"Medical risk-factors and the development of brain-tumors","volume":"69","author":"Schlehofer","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.lfs.2016.12.008_bb0960","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/(SICI)1097-0215(19990719)82:2<155::AID-IJC1>3.0.CO;2-P","article-title":"Role of medical history in brain tumour development. Results from the international adult brain tumour study","volume":"82","author":"Schlehofer","year":"1999","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.lfs.2016.12.008_bb0965","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1093\/aje\/kwh153","article-title":"Case-control study of use of nonsteroidal antiinflammatory drugs and glioblastoma multiforme","volume":"159","author":"Sivak-Sears","year":"2004","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.lfs.2016.12.008_bb0970","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1002\/ijc.25883","article-title":"Effects of antihistamine and anti-inflammatory medication use on risk of specific glioma histologies","volume":"129","author":"Scheurer","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.lfs.2016.12.008_bb0975","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/carcin\/bgl021","article-title":"H1 histamine receptor antagonists induce genotoxic and caspase-2-dependent apoptosis in human melanoma cells","volume":"27","author":"Jangi","year":"2006","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.lfs.2016.12.008_bb0980","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1023\/B:DDAS.0000043377.30075.ac","article-title":"The effect of H-2 antagonists on proliferation and apoptosis in human colorectal cancer cell lines","volume":"49","author":"Rajendra","year":"2004","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.lfs.2016.12.008_bb0985","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1182\/blood-2005-12-028456","article-title":"The CML-related oncoprotein BCR\/ABL induces expression of histidine decarboxylase (HDC) and the synthesis of histamine in leukemic cells","volume":"108","author":"Aichberger","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.lfs.2016.12.008_bb0990","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0006-291X(85)90271-2","article-title":"Evidence that the antiestrogen binding-site is a histamine or histamine-like receptor","volume":"126","author":"Brandes","year":"1985","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2016.12.008_bb0995","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1093\/jnci\/86.10.770","article-title":"Enhanced cancer growth in mice administered daily human-equivalent doses of some H-1-antihistamines - predictive in-vitro correlates","volume":"86","author":"Brandes","year":"1994","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.lfs.2016.12.008_bb1000","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.exphem.2010.05.008","article-title":"H1-receptor antagonists terfenadine and loratadine inhibit spontaneous growth of neoplastic mast cells","volume":"38","author":"Hadzijusufovic","year":"2010","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.lfs.2016.12.008_bb1005","first-page":"21","article-title":"The regulation of histidine decarboxylase gene expression","volume":"69","author":"H\u00f6cker","year":"1996","journal-title":"Yale J. Biol. Med."},{"key":"10.1016\/j.lfs.2016.12.008_bb1010","doi-asserted-by":"crossref","first-page":"226","DOI":"10.2741\/s264","article-title":"Role of histamine H4 receptors in the gastrointestinal tract","volume":"4","author":"Coruzzi","year":"2012","journal-title":"Front. Biosci. (Schol. Ed.)"},{"key":"10.1016\/j.lfs.2016.12.008_bb1015","first-page":"693","article-title":"Cimetidine induces apoptosis in gastric cancer cells in vitro and inhibits tumor growth in vivo","volume":"23","author":"Jiang","year":"2010","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.lfs.2016.12.008_bb1020","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1159\/000007686","article-title":"Does cimetidine improve prospects for cancer patients? A reappraisal of the evidence to date","volume":"60","author":"Siegers","year":"1999","journal-title":"Digestion"},{"key":"10.1016\/j.lfs.2016.12.008_bb1025","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0140-6736(79)91306-0","article-title":"Anti-tumor effect of cimetidine","volume":"1","author":"Armitage","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2016.12.008_bb1030","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1200\/JCO.1990.8.2.325","article-title":"Phase-II study of coumarin and cimetidine in patients with metastatic renal-cell carcinoma","volume":"8","author":"Dexeus","year":"1990","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lfs.2016.12.008_bb1035","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1200\/JCO.1987.5.7.1078","article-title":"Phase-II studies of single-agent cimetidine and the combination N-Phosphonacetyl-l-aspartate (Nsc-224131) plus l-Alanosine (Nsc-153353) in advanced malignant-melanoma","volume":"5","author":"Morton","year":"1987","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lfs.2016.12.008_bb1040","first-page":"1021","article-title":"Cimetidine, an unexpected anti-tumor agent, and its potential for the treatment of glioblastoma","volume":"28","author":"Lefranc","year":"2006","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.lfs.2016.12.008_bb1045","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1006\/bbrc.2001.4487","article-title":"Effect of cimetidine on intratumoral cytokine expression in an experimental tumor","volume":"281","author":"Takahashi","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2016.12.008_bb1050","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1054\/bjoc.1999.0895","article-title":"Histamine, mast cells and tumour cell proliferation in breast cancer: does preoperative cimetidine administration have an effect?","volume":"82","author":"Bowrey","year":"2000","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.lfs.2016.12.008_bb1055","doi-asserted-by":"crossref","first-page":"36781","DOI":"10.1074\/jbc.M006480200","article-title":"Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes","volume":"275","author":"Oda","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2016.12.008_bb1060","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1124\/mol.59.3.427","article-title":"Discovery of a novel member of the histamine receptor family","volume":"59","author":"Nguyen","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.lfs.2016.12.008_bb1065","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1095\/biolreprod37.3.546","article-title":"Increased number of mast-cells in the dominant follicle of the cow - relationships among luteal, stromal, and hilar regions","volume":"37","author":"Nakamura","year":"1987","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.lfs.2016.12.008_bb1070","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0022-3565(24)38851-2","article-title":"Cloning and characterization of a novel human histamine receptor","volume":"296","author":"Morse","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.lfs.2016.12.008_bb1075","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.4161\/cbt.5.11.3273","article-title":"Histamine-mediated signaling processes in human malignant mammary cells","volume":"5","author":"Medina","year":"2006","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.lfs.2016.12.008_bb1080","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1124\/mol.59.3.420","article-title":"Cloning and pharmacological characterization of a fourth histamine receptor (H-4) expressed in bone marrow","volume":"59","author":"Liu","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.lfs.2016.12.008_bb1085","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1006\/bbrc.2001.4976","article-title":"Structure and expression of the human histamine H-4-receptor gene","volume":"284","author":"Coge","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2016.12.008_bb1090","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1042\/bj3550279","article-title":"Genomic organization and characterization of splice variants of the human histamine H-3 receptor","volume":"355","author":"Coge","year":"2001","journal-title":"Biochem. J."},{"key":"10.1016\/j.lfs.2016.12.008_bb1095","doi-asserted-by":"crossref","first-page":"6807","DOI":"10.1158\/1078-0432.CCR-05-0675","article-title":"The role of cyclooxygenase-2 in mediating the effects of histamine on cell proliferation and vascular endothelial growth factor production in colorectal cancer","volume":"11","author":"Cianchi","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2016.12.008_bb1100","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1476-5381.2009.00250.x","article-title":"Molecular and biochemical pharmacology of the histamine H-4 receptor","volume":"157","author":"Leurs","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2016.12.008_bb1105","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0163-7258(95)00006-3","article-title":"Molecular pharmacological aspects of histamine-receptors","volume":"66","author":"Leurs","year":"1995","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.lfs.2016.12.008_bb1110","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s11882-003-0044-3","article-title":"New concepts of histamine receptors and actions","volume":"3","author":"Repka-Ramirez","year":"2003","journal-title":"Curr. Allergy Asthma Rep."},{"key":"10.1016\/j.lfs.2016.12.008_bb1115","doi-asserted-by":"crossref","DOI":"10.1186\/1748-717X-5-8","article-title":"Loratadine dysregulates cell cycle progression and enhances the effect of radiation in human tumor cell lines","volume":"5","author":"Soule","year":"2010","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.lfs.2016.12.008_bb1120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045063","article-title":"Astemizole synergizes calcitriol antiproliferative activity by inhibiting CYP24A1 and upregulating VDR: a novel approach for breast cancer therapy","volume":"7","author":"Garcia-Quiroz","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2016.12.008_bb1125","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.fct.2006.11.016","article-title":"Induction of apoptosis and cell-cycle arrest in human colon cancer cells by meclizine","volume":"45","author":"Lin","year":"2007","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.lfs.2016.12.008_bb1130","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0304-3835(96)04591-0","article-title":"Polyamine contents of human breast cancer cells treated with the cytotoxic agents chlorpheniramine and dehydrodidemnin B","volume":"113","author":"GomezFabre","year":"1997","journal-title":"Cancer Lett."},{"key":"10.1016\/j.lfs.2016.12.008_bb1135","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s10495-011-0640-y","article-title":"Terfenadine induces apoptosis and autophagy in melanoma cells through ROS-dependent and -independent mechanisms","volume":"16","author":"Nicolau-Galmes","year":"2011","journal-title":"Apoptosis"},{"key":"10.1016\/j.lfs.2016.12.008_bb1140","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/carcin\/bgm292","article-title":"Terfenadine-induced apoptosis in human melanoma cells is mediated through Ca2+ homeostasis modulation and tyrosine kinase activity, independently of H1 histamine receptors","volume":"29","author":"Jangi","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.lfs.2016.12.008_bb1145","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1365-2141.2009.07797.x","article-title":"The anti-histaminic cyproheptadine synergizes the antineoplastic activity of bortezomib in mantle cell lymphoma through its effects as a histone deacetylase inhibitor","volume":"146","author":"Paoluzzi","year":"2009","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.lfs.2016.12.008_bb1150","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1002\/hep.24573","article-title":"The H4 histamine receptor agonist, clobenpropit, suppresses human cholangiocarcinoma progression by disruption of epithelial mesenchymal transition and tumor metastasis","volume":"54","author":"Meng","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2016.12.008_bb1155","first-page":"121","article-title":"The effect of a short preoperative course of cimetidine on the grade of TIL in primary colorectal cancer - a randomised controlled clinical trial","volume":"3","author":"Finlay","year":"1999","journal-title":"GI Cancer"},{"key":"10.1016\/j.lfs.2016.12.008_bb1160","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/BF02148852","article-title":"An adjuvant treatment in colorectal-cancer - a double-blind, randomized pilot-study","volume":"38","author":"Svendsen","year":"1995","journal-title":"Dis. Colon Rectum"},{"key":"10.1016\/j.lfs.2016.12.008_bb1165","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1046\/j.1365-2168.2002.02223.x","article-title":"Ranitidine as adjuvant treatment in colorectal cancer","volume":"89","author":"Nielsen","year":"2002","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.lfs.2016.12.008_bb1170","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1046\/j.1365-2230.1999.00397.x","article-title":"Diffuse cutaneous mastocytosis responding to cyproheptadine","volume":"24","author":"Enomoto","year":"1999","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.lfs.2016.12.008_bb1175","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/all.12159","article-title":"Rupatadine improves quality of life in mastocytosis: a randomized, double-blind, placebo-controlled trial","volume":"68","author":"Siebenhaar","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.lfs.2016.12.008_bb1180","first-page":"48","article-title":"Evaluation of cimetwine as a therapy for dermal melanomatosis in grey horse","volume":"65","author":"Laus","year":"2010","journal-title":"Isr. J. Vet. Med."},{"key":"10.1016\/j.lfs.2016.12.008_bb1185","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/BF02939927","article-title":"The role of histamine-antagonists on the development of experimental cancer in the rat","volume":"153","author":"Nee","year":"1984","journal-title":"Ir. J. Med. Sci."},{"key":"10.1016\/j.lfs.2016.12.008_bb1190","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/bjc.1977.267","article-title":"Cytotoxicity of cyproheptadine and methysergide to chemically-induced carcinomas of rat colon","volume":"36","author":"Barkla","year":"1977","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.lfs.2016.12.008_bb1195","first-page":"495","article-title":"Effects of cimetidine on tumor-growth and immune function in nude-mice bearing human ovarian-carcinoma","volume":"74","author":"Kikuchi","year":"1985","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.lfs.2016.12.008_bb1200","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/bjc.1982.7","article-title":"Decrease in tumor-growth by injections of histamine of serotonin in fibrosarcoma-bearing mice - influence of H-1 and H-2 histamine-receptors","volume":"45","author":"Burtin","year":"1982","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.lfs.2016.12.008_bb1205","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S1065-6995(02)90934-0","article-title":"Different H2 receptor antihistamines dissimilarly retard the growth of xenografted human melanoma cells in immunodeficient mice","volume":"26","author":"Szincsak","year":"2002","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.lfs.2016.12.008_bb1210","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1136\/gut.34.8.1091","article-title":"Effect of histamine on the growth of human gastrointestinal tumors - reversal by cimetidine","volume":"34","author":"Watson","year":"1993","journal-title":"Gut"},{"key":"10.1016\/j.lfs.2016.12.008_bb1215","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1182\/blood-2008-02-142687","article-title":"Cyproheptadine displays preclinical activity in myeloma and leukemia","volume":"112","author":"Mao","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.lfs.2016.12.008_bb1220","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/0014-5793(92)80682-7","article-title":"Chlorpheniramine inhibits the ornithine decarboxylase induction of Ehrlich carcinoma growing in vivo","volume":"305","author":"Urdiales","year":"1992","journal-title":"FEBS Lett."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320516306932?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320516306932?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T15:23:54Z","timestamp":1749828234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320516306932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":244,"alternative-id":["S0024320516306932"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2016.12.008","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antihistamines as promising drugs in cancer therapy","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2016.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}